D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 61 Citations 17,113 173 World Ranking 5077 National Ranking 40

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Genetics

His primary areas of investigation include Molecular biology, Internal medicine, Endocrinology, Genetically modified mouse and Transgene. His Molecular biology research includes elements of Mutant, Gene expression, Gene, Cre recombinase and Protein structure. Thomas Rülicke has included themes like Diabetes mellitus, microRNA and Cellular differentiation in his Internal medicine study.

His research investigates the connection between Genetically modified mouse and topics such as Virology that intersect with problems in Pathogenesis, Amyloid and Nucleic acid. His work deals with themes such as Scrapie, Phenotype, Neurodegeneration, PRNP and Knockout mouse, which intersect with Transgene. Thomas Rülicke combines subjects such as Protease and Cell biology with his study of Scrapie.

His most cited work include:

  • Molecular and neuronal substrate for the selective attenuation of anxiety. (824 citations)
  • Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. (789 citations)
  • Experimental autoimmune encephalomyelitis repressed by microglial paralysis. (590 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cell biology, Transgene, Molecular biology, Immunology and Genetically modified mouse. His Cell biology research is multidisciplinary, relying on both Embryonic stem cell, Stromal cell, Pathology and Immune system. His research investigates the link between Transgene and topics such as Knockout mouse that cross with problems in Nervous system and Ectopic expression.

His work carried out in the field of Molecular biology brings together such families of science as Cell culture and Gene expression. His Immunology study deals with Cytotoxic T cell intersecting with Antigen and T cell. Thomas Rülicke combines subjects such as Scrapie, Endocrinology, Internal medicine and Virology with his study of Genetically modified mouse.

He most often published in these fields:

  • Cell biology (25.65%)
  • Transgene (17.39%)
  • Molecular biology (17.83%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (17.39%)
  • Leukemia (11.30%)
  • Stem cell (15.22%)

In recent papers he was focusing on the following fields of study:

Thomas Rülicke spends much of his time researching Cancer research, Leukemia, Stem cell, CD38 and Progenitor cell. His Cancer research research is multidisciplinary, incorporating perspectives in Leukemia lymphoma, STAT5, Transgene and Gain of function. His biological study focuses on Genetically modified mouse.

His Stem cell study incorporates themes from Multiple forms, Chronic myelomonocytic leukemia and Bone marrow. In his study, Lymphotoxin and Immune system is strongly linked to Cell, which falls under the umbrella field of Progenitor cell. His work in Phenotype covers topics such as Regulation of gene expression which are related to areas like Cell biology.

Between 2017 and 2021, his most popular works were:

  • Large-scale genetic analysis reveals mammalian mtDNA heteroplasmy dynamics and variance increase through lifetimes and generations (27 citations)
  • Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. (20 citations)
  • Structural and functional consequences of the STAT5BN642H driver mutation. (16 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Enzyme

Thomas Rülicke mainly investigates Leukemia, Cancer research, Internal medicine, Endocrinology and Myeloid leukemia. He has researched Leukemia in several fields, including CD135, Imatinib, Pharmacology and CD38. His study in Cancer research is interdisciplinary in nature, drawing from both Haematopoiesis, Steatosis, CD20, Lymphoma and CD33.

His Lymphoma research is multidisciplinary, incorporating elements of Genetically modified mouse, Transgene, Mutant and SH2 domain. Internal medicine and Diabetes mellitus are commonly linked in his work. His studies in Myeloid leukemia integrate themes in fields like Tyrosine kinase, ABL and Vildagliptin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Molecular and neuronal substrate for the selective attenuation of anxiety.

Karin Löw;Florence Crestani;Ruth Keist;Dietmar Benke.
Science (2000)

1081 Citations

Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

M B Fischer;T Rülicke;A Raeber;A Sailer.
The EMBO Journal (1996)

1015 Citations

Altered circadian activity rhythms and sleep in mice devoid of prion protein.

I Tobler;S E Gaus;T Deboer;P Achermann.
Nature (1996)

831 Citations

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

Frank L Heppner;Melanie Greter;Denis Marino;Jeppe Falsig.
Nature Medicine (2005)

785 Citations

Bi-directional interconversion of brite and white adipocytes

Matthias Rosenwald;Aliki Perdikari;Thomas Rülicke;Christian Wolfrum.
Nature Cell Biology (2013)

683 Citations

Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.

Doron Shmerling;Ivan Hegyi;Marek Fischer;Thomas Blättler.
Cell (1998)

616 Citations

Mice with Combined Gene Knock-Outs Reveal Essential and Partially Redundant Functions of Amyloid Precursor Protein Family Members

Sabine Heber;Jochen Herms;Vladan Gajic;Johannes Hainfellner.
The Journal of Neuroscience (2000)

588 Citations

ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1

Guenter Haemmerle;Tarek Moustafa;Gerald Woelkart;Sabrina Büttner.
Nature Medicine (2011)

553 Citations

IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA

Andreas Pichlmair;Caroline Lassnig;Carol-Ann Eberle;Maria W Górna.
Nature Immunology (2011)

441 Citations

Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies

Frank L. Heppner;Christine Musahl;Isabelle Arrighi;Michael A. Klein.
Science (2001)

396 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Rülicke

Adriano Aguzzi

Adriano Aguzzi

University of Zurich

Publications: 226

Burkhard Ludewig

Burkhard Ludewig

Kantonsspital St. Gallen

Publications: 78

Max Gassmann

Max Gassmann

University of Zurich

Publications: 77

Detlev Boison

Detlev Boison

Rutgers, The State University of New Jersey

Publications: 73

Ulrike Müller

Ulrike Müller

Heidelberg University

Publications: 67

John Collinge

John Collinge

University College London

Publications: 62

Stanley B. Prusiner

Stanley B. Prusiner

University of California, San Francisco

Publications: 61

David A. Harris

David A. Harris

Boston University

Publications: 57

Marco Prinz

Marco Prinz

University of Freiburg

Publications: 53

Giuseppe Legname

Giuseppe Legname

International School for Advanced Studies

Publications: 53

Markus Glatzel

Markus Glatzel

Universität Hamburg

Publications: 51

David R. Brown

David R. Brown

University of Bath

Publications: 50

Veronika Sexl

Veronika Sexl

University of Veterinary Medicine Vienna

Publications: 50

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 45

Mathias Müller

Mathias Müller

University of Veterinary Medicine Vienna

Publications: 44

Rolf M. Zinkernagel

Rolf M. Zinkernagel

University of Zurich

Publications: 41

Something went wrong. Please try again later.